A new PanCAN-authored paper uses feedback provided by patients with pancreatic cancer to identify trends in reporting pain.

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

LOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership ...

Home Aprenda Sobre el Cáncer de Páncreas La Dieta y Nutrición para Personas con Cáncer de Páncreas Controlando la Náusea y los Vómitos See this page in English La náusea y el vómito son efectos ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

It can be helpful for patients with pancreatic cancer to think through questions about personal values, as well as treatment goals, to help guide decision making.

We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic cancer.

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic neuroendocrine tumors, also called PNET or PanNET.

Right now, the House is working on the budget for the largest funder of pancreatic cancer research in the world. Take action today to tell your rep to reject proposed cuts to the National Cancer ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit outlines the latest advances in pancreatic cancer and offers key insights from ASCO GI 2025.

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...